Notable Reporting: A Reversal for ConforMIS Inc Is Not Near. The Stock Rises Again

Notable Reporting: A Reversal for ConforMIS Inc Is Not Near. The Stock Rises Again

The stock of ConforMIS Inc (NASDAQ:CFMS) is a huge mover today! About 262,906 shares traded hands. ConforMIS Inc (NASDAQ:CFMS) has declined 26.49% since April 8, 2016 and is downtrending. It has underperformed by 32.14% the S&P500.
The move comes after 6 months positive chart setup for the $445.28 million company. It was reported on Nov, 10 by Barchart.com. We have $18.48 PT which if reached, will make NASDAQ:CFMS worth $396.30M more.

ConforMIS Inc (NASDAQ:CFMS) Ratings Coverage

Out of 9 analysts covering ConforMIS Inc (NASDAQ:CFMS), 7 rate it a “Buy”, 0 “Sell”, while 2 “Hold”. This means 78% are positive. ConforMIS Inc has been the topic of 16 analyst reports since July 27, 2015 according to StockzIntelligence Inc. The stock of ConforMIS Inc (NASDAQ:CFMS) has “Buy” rating given on Monday, September 19 by SunTrust. Oppenheimer maintained it with “Outperform” rating and $27 target price in Wednesday, August 12 report. The stock of ConforMIS Inc (NASDAQ:CFMS) earned “Buy” rating by Sterne Agee CRT on Tuesday, December 1. As per Tuesday, August 9, the company rating was maintained by Oppenheimer. Wells Fargo downgraded the shares of CFMS in a report on Friday, May 13 to “Market Perform” rating. Wells Fargo initiated the shares of CFMS in a report on Monday, July 27 with “Outperform” rating. The rating was initiated by Oppenheimer with “Outperform” on Monday, July 27. The stock of ConforMIS Inc (NASDAQ:CFMS) earned “Neutral” rating by JP Morgan on Tuesday, August 9. B. Riley & Co initiated it with “Buy” rating and $13 target price in Friday, September 16 report. Canaccord Genuity initiated the stock with “Buy” rating in Monday, July 27 report.

According to Zacks Investment Research, “ConforMIS, Inc. is a medical technology company which develops, manufacture and sells joint replacement implants. The Company’s iFit technology platform consists of iFit Design, iFit Printing and iFit Just-in-Time Delivery. It operates primarily in the United States, Germany and the United Kingdom. The Company serves orthopedic surgeons, hospitals and other medical facilities and patients. ConforMIS, Inc. is based in Bedford, United States.”

More recent ConforMIS Inc (NASDAQ:CFMS) news were published by: Streetinsider.com which released: “ConforMIS Inc (CFMS) Appoints New CEO” on October 24, 2016. Also Marketwatch.com published the news titled: “Conformis shares plunge more than 30% on cut outlook, CEO search” on May 12, 2016. Streetinsider.com‘s news article titled: “ConforMIS Inc (CFMS) Tops Q3 EPS by 5c” with publication date: November 03, 2016 was also an interesting one.

CFMS Company Profile

ConforMIS, Inc., incorporated on March 26, 2004, is a medical technology firm that uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped. The Company’s products include iTotal, iTotal PS, iDuo and iUni. The Company’s iFit technology platform comprises three elements: iFit Design, iFit Printing and iFit Just-in-Time Delivery. iFit Design is the Company’s algorithms and computer software that it uses to design customized implants and associated single-use, patient-specific instrumentation, which is referred to as iJigs. iJigs is based on a computed tomography (CT) scan of the patient and to prepare a surgical plan customized for the patient that it calls iView. iFit Printing is a three-dimensional (3D) printing technology that the Company uses to manufacture iJigs. iFit Just-in-Time Delivery is its just-in-time manufacturing and delivery capability. The Firm markets and sells its products in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Singapore and Hong Kong.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment